XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 50,395 $ 21,084
Restricted cash - current 10 10
Available-for-sale securities - current 43,191 56,515
Receivable from collaboration partner - related party 520 0
Research and development tax incentive receivable 885 2,241
Prepaid expenses and other current assets 2,703 3,394
Total current assets 97,704 83,244
Property and equipment, net 945 562
Restricted cash - noncurrent 450 0
Available-for-sale securities - noncurrent 11,316 10,150
Other assets 0 34
Total assets 110,415 93,990
Current liabilities:    
Accounts payable 2,267 1,163
Accrued expenses and other payables 8,241 5,272
Deferred revenue - related party 41,739 0
Total current liabilities 52,247 6,435
Deferred rent - noncurrent 332 0
Total liabilities 52,579 6,435
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.00001 par value, 10,000,000 shares authorized; and no shares issued and outstanding as of September 30, 2017 and December 31, 2016 0 0
Common stock, $0.00001 par value, 90,000,000 shares authorized; 16,944,103 and 16,722,280 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively 0 0
Additional paid-in capital 156,234 152,393
Accumulated other comprehensive gain (loss) 100 (245)
Accumulated deficit (98,498) (64,593)
Total stockholders’ equity 57,836 87,555
Total liabilities and stockholders' equity $ 110,415 $ 93,990